Question to the Department of Health and Social Care:

To ask Her Majesty’s Government what assessment they have made of the outcome and cost effectiveness of the use of faecal microbiota transplants in the treatment of recurrent Clostridium difficile infections.

The National Institute for Health and Care Excellence (NICE) has produced guidance on faecal microbiota transplant for recurrent Clostridium difficile infection. NICE has recommended that the procedure is safe enough for use in the National Health Service, but no assessment of its cost effectiveness has been made by NICE.

Data on the uptake by the NHS of faecal microbiota transplants in the treatment of recurrent Clostridium difficile is not collected centrally.